GR1001065B - Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε,διαγνωστικα συστηματα και μεθοδοι χρησιμοποιησεως αυτων. - Google Patents

Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε,διαγνωστικα συστηματα και μεθοδοι χρησιμοποιησεως αυτων.

Info

Publication number
GR1001065B
GR1001065B GR900100621A GR900100621A GR1001065B GR 1001065 B GR1001065 B GR 1001065B GR 900100621 A GR900100621 A GR 900100621A GR 900100621 A GR900100621 A GR 900100621A GR 1001065 B GR1001065 B GR 1001065B
Authority
GR
Greece
Prior art keywords
polypeptide
analogs
methods
diagnostic systems
apolipoprotein
Prior art date
Application number
GR900100621A
Other languages
English (en)
Other versions
GR900100621A (en
Inventor
Linda K Curtiss
Cheryl A Dyer
Richard Smith
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/395,732 external-priority patent/US5177189A/en
Priority claimed from US07/485,158 external-priority patent/US5182364A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of GR900100621A publication Critical patent/GR900100621A/el
Publication of GR1001065B publication Critical patent/GR1001065B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Connection Of Plates (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η παρούσα εφεύρεσις αφορά εις πολυμερές πολυπεπτίδιον δυνάμενον να μιμηθεί την ικανότητα της apo E να προκαλεί διαφοροποιημένην κυτταρικήν λειτουργίαν. Η επαναλαμβανόμενη μονάς του πολυπεπτιδίου έχει αλληλουχίαν ριζών αμινοξέων αντιστοιχούσαν εις την αντιπροσωπευομένην υπό του τύπου LRKLRKRLLRDADDL. Θεωρείται επίσης μέθοδος θεραπείας της υπεχοληστεριναιμίας εις ασθενή, περιλαμβάνουσα την χορήγησιν εις τον ασθενή μιας υποβιβαζούσης την εις το πλάσμα συγκέντρωσιν της LDL ποσότητος του πολυπεπτιδίου. Περιγράφεται επίσης η χρήσις του πολυπεπτιδίου εις την παρασκευήν διαγνωστικών αντισωμάτων και η χρήσις αυτών εις διαγνωστικά συστήματα και μεθόδους ανιχνεύσεως αντιγόνων apo E εις αγγειακά υγρά του σώματος. ω
GR900100621A 1989-08-18 1990-08-17 Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε,διαγνωστικα συστηματα και μεθοδοι χρησιμοποιησεως αυτων. GR1001065B (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/395,732 US5177189A (en) 1989-08-18 1989-08-18 Polypeptide analogs of Apolipoprotein E
US07/485,158 US5182364A (en) 1990-02-26 1990-02-26 Polypeptide analogs of apolipoprotein E
US07/540,363 US5168045A (en) 1989-08-18 1990-06-18 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e

Publications (2)

Publication Number Publication Date
GR900100621A GR900100621A (en) 1991-12-30
GR1001065B true GR1001065B (el) 1993-04-28

Family

ID=27410184

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100621A GR1001065B (el) 1989-08-18 1990-08-17 Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε,διαγνωστικα συστηματα και μεθοδοι χρησιμοποιησεως αυτων.

Country Status (9)

Country Link
US (1) US5168045A (el)
EP (1) EP0487629A1 (el)
JP (1) JPH05501400A (el)
AU (1) AU648991B2 (el)
FI (1) FI920670A0 (el)
GR (1) GR1001065B (el)
IE (1) IE902992A1 (el)
PT (1) PT95030A (el)
WO (1) WO1991002751A1 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
CA2137814A1 (en) * 1992-06-12 1993-12-23 Maryvonne Rosseneu New peptides and proteins, process for their preparation and their use as cholesterol acceptors
JPH08502730A (ja) * 1992-08-12 1996-03-26 バイオ−テクノロジー・ジェネラル・コーポレーション アポリポタンパクｅを用いた細胞増殖を阻害する方法
DE69333461T2 (de) * 1992-10-13 2005-03-24 Duke University VERFAHREN ZUM nachweis der Alzheimer Krankheit
US20030077641A1 (en) * 1998-03-11 2003-04-24 Laskowitz Daniel T. Methods of suppressing microglial activation and systemic inflammatory responses
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
SG10201901089TA (en) 2008-11-10 2019-03-28 Arbutus Biopharma Corp Novel lipids and compositions for the delivery of therapeutics
ITTO20080894A1 (it) * 2008-12-02 2010-06-03 Bioindustry Park Del Canavese S P A Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso
EP3243504A1 (en) 2009-01-29 2017-11-15 Arbutus Biopharma Corporation Improved lipid formulation
AU2010223967B2 (en) 2009-03-12 2015-07-30 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
SG10201402054UA (en) 2009-05-05 2014-09-26 Muthiah Manoharan Lipid compositions
HUE056773T2 (hu) 2009-06-10 2022-03-28 Arbutus Biopharma Corp Továbbfejlesztett lipid készítmény
SI2453923T1 (sl) * 2009-07-14 2016-04-29 Mayo Foundation For Medical Education And Research S peptidi posredovana ne-kovalentna dostava aktivnih učinkovin preko krvno možganske bariere
AP2015008874A0 (en) 2009-08-14 2015-11-30 Alnylam Pharmaceuticals Inc Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
WO2011071860A2 (en) 2009-12-07 2011-06-16 Alnylam Pharmaceuticals, Inc. Compositions for nucleic acid delivery
AU2010330814B2 (en) 2009-12-18 2017-01-12 Acuitas Therapeutics Inc. Methods and compositions for delivery of nucleic acids
US20130156845A1 (en) 2010-04-29 2013-06-20 Alnylam Pharmaceuticals, Inc. Lipid formulated single stranded rna
US20130123338A1 (en) 2010-05-12 2013-05-16 Protiva Biotherapeutics, Inc. Novel cationic lipids and methods of use thereof
WO2011141704A1 (en) 2010-05-12 2011-11-17 Protiva Biotherapeutics, Inc Novel cyclic cationic lipids and methods of use
IL300109A (en) 2010-06-03 2023-03-01 Alnylam Pharmaceuticals Inc Biodegradable lipids for the transfer of active substances
US20130323269A1 (en) 2010-07-30 2013-12-05 Muthiah Manoharan Methods and compositions for delivery of active agents
US20130202652A1 (en) 2010-07-30 2013-08-08 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
CN110123830A (zh) 2010-11-09 2019-08-16 阿尔尼拉姆医药品有限公司 用于抑制Eg5和VEGF基因的表达的脂质配制的组合物和方法
EP3202760B1 (en) 2011-01-11 2019-08-21 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
AU2012315965A1 (en) 2011-09-27 2014-04-03 Alnylam Pharmaceuticals, Inc. Di-aliphatic substituted PEGylated lipids
US9610324B2 (en) 2012-07-11 2017-04-04 Esperion Therapeutics, Inc. Apolipoprotein mixtures
US10072065B2 (en) 2015-08-24 2018-09-11 Mayo Foundation For Medical Education And Research Peptide-mediated delivery of immunoglobulins across the blood-brain barrier
CN112375138B (zh) * 2020-11-13 2022-12-13 中元汇吉生物技术股份有限公司 一种重组载脂蛋白e和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
SE448324B (sv) * 1985-09-27 1987-02-09 Pharmacia Ab Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner
US4828986A (en) * 1986-09-29 1989-05-09 Scripps Clinic And Research Foundation Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
ZA884504B (en) * 1987-06-29 1989-03-29 Merrell Dow Pharma Immunosuppressant peptides

Also Published As

Publication number Publication date
US5168045A (en) 1992-12-01
JPH05501400A (ja) 1993-03-18
AU6337090A (en) 1991-04-03
PT95030A (pt) 1991-04-18
EP0487629A1 (en) 1992-06-03
WO1991002751A1 (en) 1991-03-07
GR900100621A (en) 1991-12-30
IE902992A1 (en) 1991-02-27
AU648991B2 (en) 1994-05-12
FI920670A0 (fi) 1992-02-17

Similar Documents

Publication Publication Date Title
GR1001065B (el) Πολυπεπτιδικα αναλογα της απολιποπρωτεινης ε,διαγνωστικα συστηματα και μεθοδοι χρησιμοποιησεως αυτων.
ATE295176T1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE59107192D1 (de) Medizinische Vorrichtung zur Erzeugung eines alternierenden Volumenstroms für den Antrieb von implantierbaren Blutpumpen
EP0245362A4 (en) SYNTHETIC PEPTIDES AND THEIR USE FOR DIAGNOSIS AND VACCINATION AGAINST AIDS AND ITS ASSOCIATED COMPLEX.
ES554155A0 (es) Un procedimiento para la preparacion de un proteina envolvente de un virus de sindrome de inmunodeficiencia adquirida
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
DK0497915T3 (da) hPTH-fragment(1-37), fremstilling heraf, lægemiddel, som indeholder det, samt anvendelse heraf
DE3877154D1 (de) Verfahren zur verhinderung der bildung von blutgerinnseln in dem extrakorporalen kreislauf eines dialyseapparats sowie dazu geeignetes mittel.
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
Payne et al. Electrophoretic mobility in paper of isoagglutinins
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
Wallas et al. Isolation of a Kell‐reactive protein from red cell membranes
Griffith et al. Preparation of high specific activity plasma AHF by anti-FVIIIC immunoaffinity chromatography
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
Sagisaka et al. Actions of proteolytic enzymes on agglutinability of M and N blood-group red cells
ATE80306T1 (de) Mittel zur absorptionsverbesserung von proteinen.
Nilsson et al. Tolerance induction in high-responding hemophiliacs with F VIII antibodies by means of combined treatment with IgG, cyclophosphamide and F VIII
Sinden Identification of specific antibodies prepared against purified immobilization antigens of Paramecium aurelia
Mackie et al. The Functional Heterogeneity Of Clinical FVIII Concentrates
Cunningham-Rundles et al. CHANGES IN ANTI-CARD10LIPIN ANTIBODY TITER IN SERA OF I TP PATIENTS AFTER TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN
Nordfang et al. IMMUNOASSAY FOR FACTOR VIII-HEAVY CHAIN. AN INDICATOR FOR IMMUNE COMPLEXES DURING HIGH DOSE FVIII INHIBITOR TREATMENT